Merck has had a successful track record of beating estimates, having surpassed EPS expectations 88% of the time and beating ...

Regeneron Pharmaceuticals is on the cusp of unveiling its Q2 2025 earnings this Friday, with expectations pinned at $8.53 per share and a revenue forecast of $3.30 billion. Analysts are eyeing a ...

Cincinnati, Ohio-based The Kroger Co. (KR) operates as a food retailer in the United States. With a market cap of $47.2 ...

Neogen (NASDAQ:NEOG) is scheduled to announce Q4 earnings results on Tuesday, July 29th, before market open.The consensus EPS Estimate is $0.09 (-10.0% Y/Y) and the consensus Revenue Estimate is $222.

John G Ullman & Associates Inc. made a hefty bet on Regeneron Pharmaceuticals, upping their stake by a whopping 94%, now ...